|
| |
|
|
| |
|
|
2008 iBio
(May 18-22, 2008,Hangzhou,China)
|
|
|
|
|
|
|
|
|
|
|
|
|
CEMD-2008
(
Oct.22-28, 2008, Beijing & Xi'an, China )
|
|
|
WCV 2008
( Dec.1-5, 2008, Guangzhou, China) |
|
|
|
|
|
|
WCG 2008
(Dec. 5-7, 2008, Guangzhou, China)
|
|
|
|
|
|
| |
| Scientific Program |
|
|
|
|
2008 IDDST Tentative Program
Time: October 18-22, 2008
Venue: Loong Palace Hotel, Beijing, China
|
| Morning of October 18 |
|
Opening Ceremony & Keynote Forum
For Detail Track Info: Click here
|
| Morning of October 19 |
|
Plenary Lectures
-- From Novel Targets to Billion Dollar Molecules
Special Symposium Sponsored by ACS-Medichem Division
|
Morning of October 20 |
|
Track 2: How Advanced Medicinal Chemistry Help Your prototype molecules to Blockbusters
-Listen to Successful Case Story from Big Phmarmas and Enjoy the Voice of ACS Medichem

|
Morning of October 20 |
|
Track 3: Translational Cutting-Edge Technologies
-Speeding Discovery Process with Niches
For Detail Track Info: Click here, Session 26-35
|
Morning of October 20, Afternoon of October 21, Morning of October 22 |
|
Track 4: Therapeutics Development for Major and Rare Diseases
-Delivering Promises for Future Drugs
For Detail Track Info: Click here, Session 36-55
|
Morning of October 22 |
|
Track 5:: Nature Product Based Drug Discovery
-Mining 5000 Year Nature Pool
For Detail Track Info: Click here, Session 56-60
|
Morning of October 22 |
|
Track 6: Drug R & D Partnering in China
-Integrating Resources and Talents from the East To Slow Your Money Burning Rate Increase pipeline successful percentage
For Detail Track Info: Click here, Session 61-65
|
|
Time |
Activities |
Oct.18, 2008
Saturday
08:20-12:10 |
Opening Ceremony |
08:20-08:40 |
Group Photo |
09:00-09:05 |
Chair's Opening Remark |
| 09:05-09:35 |
VIP's Address |
09:40-10:05 |
Title: The Secret Life of Enzymes
Prof. K. Barry Sharpless, 2001 Nobel Laureate in Chemistry, The Scripps Research Institute, USA |
10:05-10:30 |
Title: Innovation in Drug Discovery
Dr. Joel C Barrish, Vice President, Immunology and Metabolic Diseases Chemistry, Bristol-Myers Squibb, USA |
| 10:30-10:55 |
Title: TBD
Dr. Andreas Tschirky, Roche's Head of R&D in China |
| 10:55-11:20 |
Reserved for Domestic Expert |
| 11:20-11:45 |
Title: Evolution of Influenza via Recombination, with Emphasis on H5N1 and Vaccine Target Development
Dr. Henry L. Niman, President, Founder, Recombinomics, Inc. USA |
| 11:45-12:10 |
Reserved for Industrial Leader (Available for Sponsorship) |
|
|
The Main Scientific Program will take place from 09:00-17:00 during October 18-22, 2008. 500+ Research and Industrial Presentations divided into six tracks with sixty-five sessions in total. The ten sessions offered will run concurrently per half day.
Click following session number for detailed program:
|
| Track 1: Drug Discovery Sciences |
¡øTOP |
| -Great Thoughts for Deciphering Human Disorders |
| |
Time |
Sessions |
Oct.18, 2008
Saturday
13:30-17:30
|
Session 1:
¡°-Omics¡±, Molecular Genetics to System Biology and Drug Discovery |
Session Chair: |
Dr. Christian Pasquali, Professor, Geneva Research Center, Merck Serono International S.A., Switzerland |
Co-Chair: |
Dr. Guochun Liao, Group Leader, Roche Pharmaceuticals, USA |
| 13:30-13:55 |
Title: Principals for Omic Medicine
Dr. Ira L. Goldknopf, Director of Proteomics, Power3 Medical Products, Inc., USA |
| 13:55-14:20 |
Title: System Biology, Gene Biomarker in Preclinical Drug Development
Dr. Ying Jiang, Research Fellow Merck & Co., Inc. |
| 14:20-14:45 |
Title: TBD
Dr. Anuradha Acharya, Founder and CEO, Ocimum Biosolutions, USA |
| 14:45-15:10 |
Title: The Use of Support Vector Machine (SVM) Technology to Develop Molecular Diagnostic Tests
Dr. Stephen D. Barnhill, Chairman and Chief Executive Officer, Health Discovery Corporation, USA |
| 15:10-15:25 |
Coffee Break |
| 15:25-15:50 |
Title: A Chemical Proteomics Approach to Phosphatidylinositol 3-Kinase Signaling in Macrophages
Dr. Christian Pasquali, Professor, Geneva Research Center, Merck Serono International S.A., Switzerland |
| 15:50-16:15 |
Title: Genomewide Identification of Gene-gene Interactions Associated with the Susceptibility to Disease
Dr. Sara Marsal Barril, Senior Consultant in Rheumatology, Rheumatology Unit, Hospital Universitari Vall d'Hebron, Spain |
| 16:15-16:40 |
Title: Computational Genetics: Toward Understanding Our Drugs and Diseases
Dr. Guochun Liao, Group Leader, Roche Pharmaceuticals, USA |
| 16:40-17:05 |
Title: Nutrigenomic and Immunosenescence
Dr. Eugenio Mocchegiani, Immunology Centre, (Section: Nutrition, Immunity and Ageing). Res. Dept. Italian National Research Centres on Ageing (I.N.R.C.A); Italy. |
| 17:05-17:30 |
Title: TBD
Dr. Dean W. Felsher, Associate Professor, Stanford University, USA |
| 17:30-17:55 |
Title: Arsenic Trioxide - Teaching An Old Drug New Tricks
Dr. Meir Wetzler, Chief, Leukemia Section, Roswell Park Cancer Institute, USA |
| 17:55-18:15 |
Only One Speech Opportunity is Available |
|
Oct.18, 2008
Saturday
13:30-17:30
|
Session 2:
Regenerative Medicine and Drug Discovery |
Session Chair: |
Dr. Christophe Labie, Head, Neurobiology Group, Sanofi-aventis, Inc., France |
Co-Chair: |
Dr. Xianmin Zeng, Assistant Professor, Buck Institute for Age Research, USA |
| 13:30-13:55 |
Title: Polymeric Artificial Cells Containing Stem Cells for Regenerative Medicine
Dr. Thomas Ming Swi Chang, Director, Artificial Cells & Organs Research Centre, McGill University, Canada |
| 13:55-14:20 |
Title: Stimulation of Brain Neurogenesis: A Way to Replace Neuron Loss in Diseased or Injured Brain
Dr. Christophe Labie, Head, Neurobiology Group, Sanofi-aventis, Inc., France |
| 14:20-14:45 |
Title: Transdifferentiation of Bone Marrow Stromal Cells into Neuronal Cells and Its
Application for Regenerative Medicine
Dr. Masaaki Kitada, Associate Professor, Department of Stem Cell Biology and Histology, Tohoku Univeristy Graduate School of Medicine, Japan |
| 14:45-15:10 |
Title: Human Embryonic Stem Cells: the Potential in Drug Discovery
Dr. Xianmin Zeng, Assistant Professor, Buck Institute for Age Research, USA
|
| 15:10-15:25 |
Coffee Break |
| 15:25-15:50 |
Title: Stem cells and Regenerative Medicine
Dr. Michele De Luca, Full Professor of Biochemistry and Director, Centre for Regenerative Medicine, Department of Biomedical Sciences, University of Modena and Reggio Emilia, Italy |
| 15:50-16:15 |
Title: TBD
Dr. Hui Zhen Sheng, Laboratory of Stem Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, China. |
| 16:15-16:40 |
Title: Development of Cellular Models for alpha-synuclein Dependent Neurodegeneration
Dr. Poul Henning Jensen, Head, Professor, University of Aarhus, Denmark |
| 16:40-17:05 |
Title: TBD
Dr. Debu Banerjee, Associate Professor of Medicine, Pharmacology Department, Robert Wood Johnson Medical School, The University of Medicine & Dentistry of New Jersey, USA |
| 17:05-17:30 |
Title: TBD
Dr. Rong-Tsun Wu, Professor & Director, Research Center for Drug Discovery, Institute of Biopharmaceutical Science, National Yang-Ming University, Taiwan |
| 17:30-17:50 |
Only One Speech Opportunity is Available |
| 17:50-18:00 |
Panel Discussion
3-5 topics will be proposed by Session Chair |
|
Oct.18, 2008
Saturday
13:30-17:30
|
Session 3:
Molecular/Cell Biology and Drug Discovery |
Session Chair: |
Dr. Michael R. Briggs, Senior Director and Head of Cell & Molecular Biology, Vertex Pharmaceuticals, Inc., USA |
Co-Chair: |
Dr. Jingwen Liu, Principal Investigator, VA Palo Alto Health Care System, USA |
| 13:30-13:50 |
Title: Finding Novel Cancer Drugs that Address Unmet Medical Needs
Dr. Michael R. Briggs, Senior Director and Head of Cell & Molecular Biology, Vertex Pharmaceuticals, Inc., USA |
| 13:50-14:10 |
Title: P25/CDK5 Inhibitors for AD Therapeutics
Dr. Ilho Ha, Director, BioScience Center Hanwha Chemical R&D Institute Hanwha Chemical Co., Korea
|
| 14:10-14:30 |
Title: DNA polymerase inhibitors for HBV therapy
Dr. Howard Li, Vertex Pharmaceuticals, Inc., USA |
| 14:30-14:50 |
Title: TBD
Dr. Huichuan Sun, Porfessor, Liver Cancer Institute of Fudan University, China |
| 14:50-15:05 |
Coffee Break |
| 15:05-15:25 |
Title: Peptide Inhibitors of Metastasis in Liver Cancer
Dr. Yinkun Liu, Deputy Director, Liver Cancer Institute of Fudan University, China |
| 15:25-15:45 |
Title: The Identifications of the Molecular Targets for Berberine Mediated Cholesterol Reduction in Plasma and in Liver
Dr. Jingwen Liu, Principal Investigator, VA Palo Alto Health Care System, USA |
| 15:45-16:05 |
Title: Wisdom: Grid Computing Enabled Identification of Active Molecules against Targets Implicated in Malaria
Dr. Vincent Breton, Research Associate, CNRS-IN2P3 Laboratory, France |
| 16:05-16:25 |
Title: The mosquito Sodium Channel: Adaptive Changes of Amino Acid and Codon Biases in the Evolution of Pyrethroid Resistance
Dr. Nannan Liu, Associate professor, Department of Entomology and Plant Pathology, Auburn University, Auburn, USA
|
| 16:25-16:45 |
Title: Novel Technologies for Expediting Drug Discovery Research
Dr. Keming Song, R&D Manager, Sigma-Aldrich Corporation, USA |
| 16:45-17:05 |
Title: TBD
Dr. Ban H Tan, MRCP ( UK ) Head, Dept of Infectious Diseases Singapore General Hospital, Singapore |
| 17:05-17:25 |
Only One Speech Opportunity is Available |
|
Oct.18, 2008
Saturday
13:30-17:30
|
Session 4:
Immunology and Drug Discovery |
Session Chair: |
Dr. Prakash Nagarkatti, Associate Dean for Basic Science, University of South Carolina School of Medicine, USA |
Co-Chair: |
Call for Co-Host |
| 13:30-13:55 |
Title: Use of Cannabinoids as Novel Anti-inflammatory Drugs through Potential Targeting of CB2 Receptors
Dr. Prakash Nagarkatti, Associate Dean for Basic Sciences, University of South Carolina School of Medicine, USA |
| 13:55-14:20 |
Title: Control of T cell Cytokine Profile during Pregnancy
Dr. Marie-Pierre Piccinni, Professor, University of Florence, Italy |
| 14:20-14:45 |
Title: TBD
Dr Sofia Kalaboka, Pediatrician ¨C Allergist, DU Immunotherapy, DU Eating Disorders, France |
| 14:45-15:10 |
Title: The Interleukin-6 Inflammation Pathway from Cholesterol to Aging ¨C Role of Statins, Bisphosphonates and Plant Polyphenols in Aging and Age-related Diseases
Dr. Sota Omoigui, Director, Division of Inflammation and Pain Medicine, L.A Pain Clinic, USA |
| 15:10-15:25 |
Coffee Break |
| 15:25-15:50 |
Title: Neural Mechanism Involved in Chagas Cardiomyooathy: From Neurogenic to Immunogenic Trophic Theories
Dr. Rafael Bonfante-Cabarcas, Director of Biomedical Science PhD Program, Department of Functional Science, School of Medicine, Universidad Cent occidental "Lisandro Alvarado", Venezuela |
| 15:50-16:15 |
Title: TBD
Dr. Yasmin Thanavala, Professor and Member, Roswell Park Cancer Institute, USA |
| 16:15-16:40 |
Title: Ligand-Mediated Targeting of Therapeutic Agents to Cancer Tissues and Sites of Inflammation
Dr. Philip S. Low, Ralph C. Corley Distinguished Professor, Department of Chemistry, Purdue University, USA |
| 16:40-17:05 |
Title: TBD
Dr. Ana Paula de Mattos Areas, Natural and Human Sciences Center, Federal University of ABC, Brazil |
| 17:05-17:30 |
Only One Speech Opportunity is Available |
| 17:30-17:50 |
Panel Discussion
3-5 topics will be proposed by Session Chair |
|
Oct.18, 2008
Saturday
13:30-17:30
|
Session 5:
Oncology and Drug Discovery |
Session Chair: |
Dr. Mitzi Nagarkatti, Deputy Director of Cancer, University of South Carolina, USA |
Co-Chair: |
Dr. M. Asif Chaudry, University Department of Surgery Royal Free & University College London, UK |
| 13:30-13:55 |
Title: Tumor-Selective Anticancer Drugs from Amphiphilic Organophosphazenes
Dr. Youn Soo Sohn, Distinguished Professor, Department of Chemistry, Division of Nano Science, Ewha Womans University, Korea |
| 13:55-14:20 |
Title: Targeting the Cannabinoid System as a Novel Therapeutic Modality to Treat Cancers of the Immune System
Dr. Mitzi Nagarkatti, Deputy Director of Cancer, University of South Carolina, USA |
| 14:20-14:45 |
Title: Fragment Based Drug Discovery Using Rational Design
Dr. Harren Jhoti, Chief Executive Officer, Astex Therapeutics, Cambridge, UK |
| 14:45-15:10 |
Title: Multifunctional Antibody Treatment Targeting EpCAM in GI
Dr. M Asif Chaudry, University Department of Surgery Royal Free & University College London, UK |
| 15:10-15:25 |
Coffee Break |
| 15:25-15:50 |
Title: Membrane Transporters in Oncology Drug Discovery
Dr. Laszlo Homolya, Senior Scientist, Research Group for Membrane Biology, Semmelweis¡¡University, Hungarian Academy of Sciences, Hungary |
| 15:50-16:15 |
Title: Targeting Multidrug Resistant Cancer
Dr. Gergely Szak¨¢cs, Professor, Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, Hungary
|
| 16:15-16:40 |
Title: Target Therapy in Cancer
Dr. Valentina Tzekova, Professor, University Hospital ¡°Queen Joanna¡±, Bulgaria |
| 16:40-17:05 |
Title: Solasodine Rhamnosyl Glycosides a New Treatment for Skin Cancer
and New Hope for Other Cancers from Nature's Pharmacy
Dr. Bill E Cham, Biochemist, Department of Medicine, University of Queensland, Royal Brisbane Hospital, Queensland, Australia |
| 17:05-17:30 |
Title: Identification of Cyano Indenopyrazine Derivatives as a Novel Series of Potent Ubiquitin-Specific Protease Inhibitors
Dr. Fr¨¦d¨¦ric Colland, Director, Biological Research, Hybrigenics, France |
| 17:30-17:50 |
Only One Speech Opportunity is Available |
|
Oct.18, 2008
Saturday
13:30-17:30
|
Session 6:
Microbiology, Virology and Drug Discovery |
Session Chair: |
Call for Host |
Co-Chair: |
Dr. Grace Wong, Founder, President & CSO, ActoKine Therapeutics, USA |
| 13:30-13:55 |
Keynote Speaker
Title: Discovering Enteric Dialysis ¨C The Gut Based Uremia Therapy for Chronic Kidney Failure Applications
Dr. Natarajan Ranganathan, Interim CEO, Kibow Biotech, USA |
| 13:55-14:20 |
Title: TBD
Dr. Ivan Diamond, Vice-President, Neuroscience, CV Therapeutics, Inc., USA |
| 14:20-14:45 |
Title: Identification of AK-1 for Oxidative Stress and AK-2 for Protection against a Broad-spectrum Viral Infection
Dr. Grace Wong, Founder, President & CSO, ActoKine Therapeutics, USA
|
| 14:45-15:10 |
Title: TBD
Dr. Michael Bukrinsky, Professor and Vice Chair, The George Washington University, USA |
| 15:10-15:25 |
Coffee Break |
| 15:25-15:50 |
Title: TBD
Dr. Mia Levite, Senior Scientist/Lecturer, The Weizmann Institute of Science, Israel |
| 15:50-16:15 |
Title: A System-biology Based Examination of Antibiotic Resistance toward New Therapy Development
Dr. Hsun-Cheng Su, Ph.D. Research Associate, Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, USA |
| 16:15-16:40 |
Title: Low cost integral aproaches for Pertussis Vaccines for Neonates, Infants and Adolecents developed at Instituto Butantan - Brazil
Dr. Luciana C.C. Leite, Centro de Biotecnologia, Instituto Butantan, Brasil |
| 16:40-17:05 |
Title: TBD
Dr. Terje Pedersen, Centre for Preventive Medicine, Ullev?l University Hospital, University of Oslo, Norway |
| 17:05-17:30 |
Only One Speech Opportunity is Available |
| 17:30-17:50 |
Panel Discussion
3-5 topics will be proposed by Session Chair |
|
Oct.18, 2008
Saturday
13:30-17:30
|
Session 7:
Neurology and Drug Discovery |
Session Chair: |
Dr. Adrian Newman-Tancredi, Director, Neurobiology 2 Division, Institut de Recherche Pierre Fabre, France |
Co-Chair: |
Dr. Xueqing Wang, Associate Research Investigator, Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, USA |
| 13:30-13:50 |
Title: Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases): What can be Learned by Studies on Cu(II)-peptide Complexes
Dr. Gianni Valensin, Professor, Director of the NMR Centre of the University of Siena, Italy |
| 13:50-14:10 |
Title: Opioid Antagonist Treatment and Alcohol Consumption: Role of Dose, Gender and Pharmacologic Strategy
Dr. Jorge Ju¨¢rez, Professor, Universidad de Guadalajara, M¨¦xico |
| 14:10-14:30 |
Title: TCA Cycle May Play an Important Role for Protection Against Epileptic Seizures
Dr. Hiro-aki Yamamoto, Associate Professor, University of Tsukuba, Japan |
| 14:30-14:50 |
Title: Serotonin 5-HT 1A Receptors : How New Mechanisms are Driving Innovation and Drug Discovery
Dr. Adrian Newman-Tancredi, Director, Neurobiology 2 Division, Institut de Recherche Pierre Fabre, France |
| 14:50-15:05 |
Coffee Break |
| 15:05-15:25 |
Title: Neurovascular Dysfunction in Dementia: Cholinesterase Inhibitors
Dr. Sabina Janciauskiene, Lund University, Department of Clinical Sciences,
Sweden
|
| 15:25-15:45 |
Title: TBD
Dr. Jeffrey N. Agar, Chemistry and Neuroscience, Brandeis University |
| 15:45-16:05 |
Title: TBD
Dr. Rajendra D Badgaiyan, Assistant Professor, Harvard Medical School, USA |
| 16:05-16:25 |
Title: Nonhuman Primates as Surrogates for Humans in Predicting Drug Effects on Cognitive Function: Using Identical Behavioral Tasks in Humans and Laboratory Animals
Dr. Merle G. Paule, Director, Division of Neurotoxicology, National Center for Toxicological Research, USA
|
| 16:25-16:45 |
Title: Investigating Effects of Anesthetics on Bbeta Amyloid Peptide Accumulation and Aggregation, the Key Pathogenic Event in Alzheimer Disease
Dr. Vincenzo Fodale, Aggregate Professor, University of Messina, Italy |
| 16:45-17:05 |
Title: TBD
Dr. Xueqing Wang, Associate Research Investigator, Neuroscience Research, Global Pharmaceutical Research and Development, Abbott Laboratories, USA |
| 17:05-17:25 |
Title: Kruppel-Like Transcription Factors Regulate Hypothalamic TRH Neuronal Phenotype Differentiation
Dr. Carlos P¨¦rez-Monter, Instituto de Biotecnolog ¨ª a, Departamento de Gen¨¦tica del Desarrollo y Fisiolog ¨ª a Molecular, M¨¦xico |
| 17:25-17:45 |
Only One Speech Opportunity is Available |
|
Oct.18, 2008
Saturday
13:30-17:30
|
Session 8:
Hepatology and Drug Discovery |
Session Chair: |
Dr. Michael S Roberts, Professor, University of Queensland, Australia |
Co-Chair: |
Dr. Hanry Yu, Associate Professor, National University of Singapore, Singapore |
| 13:30-13:55 |
Title: Detecting and Managing pre-clinical Signals of Drug Hepatotoxicity
Dr. Gerry Kenna, Principal Scientist in Molecular Toxicology, AstraZeneca Ltd, UK |
| 13:55-14:20 |
Title: Drug Structure- Hepatic Pharmacokinetic Relationships in Normal and Diseased Livers
Dr. Michael S Roberts, Professor, University of Queensland, Australia |
| 14:20-14:45 |
Title: Chemoembolizattion of Hepatic Neoplasm with Drug-eluting Microspheres
Dr. T. Gregory Walker, Associa | | | | |